GPX3 and chronic kidney disease: In contrast to the differences in E-GPx (GPx1) activity in CKD patients, which were found in the reports of various authors, P-GPx (GPx3) activity has been shown to be reduced in CKD consistently by 34–52% as compared with healthy subjects.